Replies to post #247364 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

It was a voluntary delist, even if it was driven by an unfortunate confluence of events and circumstances that shorts were salivating to make otherwise... their salivating maws just sitting below, waiting for the IP and assets to drop into their ravenous guts virtually for free...

Just because you believe otherwise, as to the voluntary delist, anticipating your reply, does not make it otherwise.

[JerryCampbell]

I have the facts correct, but you seem to have forgotten. Let's go to the SEC filings.

"As reported in the Company’s quarterly report on form 10-Q, on November 7, 2016 the Company received a letter from Nasdaq indicating that certain of the Company’s financing transactions did not comply with Nasdaq’s Listing Rule 5635(d). The Nasdaq Staff had determined to aggregate a series of transactions that were completed between May 15, 2016 and October 13, 2016 for purposes of assessing whether the 20% threshold for shareholder approval had been triggered for issuances priced below the applicable market price. These transactions included repricing of existing common stock purchase warrants and issuances of new common shares and common stock purchase warrants."

https://www.sec.gov/Archives/edgar/data/1072379/000114420416134282/v453089_8k.htm


DID NOT COMPLY WITH NASDAQ'S LISTING RULE - seems like pretty clear English. And it was nwbo's second violation of the same rule.